These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 1677697

  • 1. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
    Nelson SR, Hawkins PN, Richardson S, Lavender JP, Sethi D, Gower PE, Pugh CW, Winearls CG, Oliver DO, Pepys MB.
    Lancet; 1991 Aug 10; 338(8763):335-9. PubMed ID: 1677697
    [Abstract] [Full Text] [Related]

  • 2. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM, Deveaux M, Duneton O, Foissac-Gegoux P, Dumont A, Duquesnoy B, Marchandise X.
    Nephrologie; 1995 Aug 10; 16(6):419-25. PubMed ID: 8524449
    [Abstract] [Full Text] [Related]

  • 3. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
    Floege J, Schäffer J, Koch KM.
    Nephrol Dial Transplant; 2001 Aug 10; 16 Suppl 4():12-6. PubMed ID: 11402091
    [Abstract] [Full Text] [Related]

  • 4. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
    Hachulla E, Maulin L, Deveaux M, Facon T, Blétry O, Vanhille P, Wechsler B, Godeau P, Levesque H, Hatron PY, Huglo D, Devulder B, Marchandise X.
    Am J Med; 1996 Jul 10; 101(1):77-87. PubMed ID: 8686719
    [Abstract] [Full Text] [Related]

  • 5. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
    Hawkins PN, Aprile C, Capri G, Viganò L, Munzone E, Gianni L, Pepys MB, Merlini G.
    Eur J Nucl Med; 1998 Jul 10; 25(7):701-8. PubMed ID: 9662591
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
    Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, Hawkins PN, Jager PL.
    Am J Med; 2006 Apr 10; 119(4):355.e15-24. PubMed ID: 16564782
    [Abstract] [Full Text] [Related]

  • 7. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R, Deveaux M, Hachulla E, Descamps J, Duquesnoy B, Marchandise X.
    Eur J Nucl Med; 1993 Feb 10; 20(2):130-7. PubMed ID: 8440269
    [Abstract] [Full Text] [Related]

  • 8. Clinical, radiological and serum amyloid P component scintigraphic features of beta2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis.
    Tan SY, Baillod R, Brown E, Farrington K, Soper C, Percy M, Clutterbuck E, Madhoo S, Pepys MB, Hawkins PN.
    Nephrol Dial Transplant; 1999 Jun 10; 14(6):1467-71. PubMed ID: 10383009
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN, Lavender JP, Pepys MB.
    N Engl J Med; 1990 Aug 23; 323(8):508-13. PubMed ID: 2377176
    [Abstract] [Full Text] [Related]

  • 10. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
    Zingraff J, Caillat-Vigneron N, Ureña P, Gagné ER, Bererhi L, Moretti JL, Bardin T, Drüeke TB.
    Nephrol Dial Transplant; 1995 Aug 23; 10(2):223-9. PubMed ID: 7753457
    [Abstract] [Full Text] [Related]

  • 11. Osteoarticular amyloidosis associated with haemodialysis: an immunoultrastructural study.
    Depierreux M, Goldman M, Fayt I, Richard C, Quintin J, Dhaene M, Van Herweghem JL.
    J Clin Pathol; 1988 Feb 23; 41(2):158-62. PubMed ID: 3280607
    [Abstract] [Full Text] [Related]

  • 12. Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin.
    Floege J, Burchert W, Brandis A, Gielow P, Nonnast-Daniel B, Spindler E, Hundeshagen H, Shaldon S, Koch KM.
    Kidney Int; 1990 Dec 23; 38(6):1169-76. PubMed ID: 2074658
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Imaging techniques in the diagnosis of dialysis-related amyloidosis.
    Ketteler M, Koch KM, Floege J.
    Semin Dial; 2001 Dec 23; 14(2):90-3. PubMed ID: 11264773
    [Abstract] [Full Text] [Related]

  • 15. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
    Hawkins PN, Richardson S, MacSweeney JE, King AD, Vigushin DM, Lavender JP, Pepys MB.
    Q J Med; 1993 Jun 23; 86(6):365-74. PubMed ID: 8171184
    [Abstract] [Full Text] [Related]

  • 16. 'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.
    Maulin L, Hachulla E, Deveaux M, Janin A, Wechsler B, Godeau P, Rousset H, Barrier JH, Hatron PY, Devulder B, Huglo D, Marchandise X.
    QJM; 1997 Jan 23; 90(1):45-50. PubMed ID: 9093588
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis.
    Dezutter NA, Landman WJ, Jager PL, de Groot TJ, Dupont PJ, Tooten PC, Zekarias B, Gruys E, Verbruggen AM.
    Amyloid; 2001 Sep 23; 8(3):202-14. PubMed ID: 11676297
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component.
    Hawkins PN, Myers MJ, Lavender JP, Pepys MB.
    Lancet; 1988 Jun 25; 1(8600):1413-8. PubMed ID: 2898580
    [Abstract] [Full Text] [Related]

  • 20. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease.
    Lovat LB, Madhoo S, Pepys MB, Hawkins PN.
    Gastroenterology; 1997 Apr 25; 112(4):1362-5. PubMed ID: 9098022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.